Collecting and Providing 702(b) Portions of FDA Official Samples: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 1, 2022
October 1, 2024
784eb4d1-7052-4789-b216-73f085854015
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Processes and Practices Applicable to Bioresearch Monitoring Inspections: Draft Guidance for Industry
Guidance DocumentJune 5, 2024Office of Inspections and Investigations
Combined Food and Drug Administration and Sponsor Oncologic Drugs Advisory Committee Briefing Document
Guidance DocumentDecember 27, 2024Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox